WO2010128359A1 - Tablet production module and method for continuous production of tablets - Google Patents
Tablet production module and method for continuous production of tablets Download PDFInfo
- Publication number
- WO2010128359A1 WO2010128359A1 PCT/IB2009/051885 IB2009051885W WO2010128359A1 WO 2010128359 A1 WO2010128359 A1 WO 2010128359A1 IB 2009051885 W IB2009051885 W IB 2009051885W WO 2010128359 A1 WO2010128359 A1 WO 2010128359A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tablet press
- tablets
- module
- inlet
- mixing unit
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29B—PREPARATION OR PRETREATMENT OF THE MATERIAL TO BE SHAPED; MAKING GRANULES OR PREFORMS; RECOVERY OF PLASTICS OR OTHER CONSTITUENTS OF WASTE MATERIAL CONTAINING PLASTICS
- B29B13/00—Conditioning or physical treatment of the material to be shaped
- B29B13/06—Conditioning or physical treatment of the material to be shaped by drying
- B29B13/065—Conditioning or physical treatment of the material to be shaped by drying of powder or pellets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29B—PREPARATION OR PRETREATMENT OF THE MATERIAL TO BE SHAPED; MAKING GRANULES OR PREFORMS; RECOVERY OF PLASTICS OR OTHER CONSTITUENTS OF WASTE MATERIAL CONTAINING PLASTICS
- B29B7/00—Mixing; Kneading
- B29B7/30—Mixing; Kneading continuous, with mechanical mixing or kneading devices
- B29B7/34—Mixing; Kneading continuous, with mechanical mixing or kneading devices with movable mixing or kneading devices
- B29B7/38—Mixing; Kneading continuous, with mechanical mixing or kneading devices with movable mixing or kneading devices rotary
- B29B7/46—Mixing; Kneading continuous, with mechanical mixing or kneading devices with movable mixing or kneading devices rotary with more than one shaft
- B29B7/48—Mixing; Kneading continuous, with mechanical mixing or kneading devices with movable mixing or kneading devices rotary with more than one shaft with intermeshing devices, e.g. screws
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29B—PREPARATION OR PRETREATMENT OF THE MATERIAL TO BE SHAPED; MAKING GRANULES OR PREFORMS; RECOVERY OF PLASTICS OR OTHER CONSTITUENTS OF WASTE MATERIAL CONTAINING PLASTICS
- B29B7/00—Mixing; Kneading
- B29B7/30—Mixing; Kneading continuous, with mechanical mixing or kneading devices
- B29B7/58—Component parts, details or accessories; Auxiliary operations
- B29B7/72—Measuring, controlling or regulating
- B29B7/726—Measuring properties of mixture, e.g. temperature or density
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C43/00—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
- B29C43/02—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor of articles of definite length, i.e. discrete articles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C43/00—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
- B29C43/32—Component parts, details or accessories; Auxiliary operations
- B29C43/34—Feeding the material to the mould or the compression means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C43/00—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
- B29C43/32—Component parts, details or accessories; Auxiliary operations
- B29C43/50—Removing moulded articles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C43/00—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
- B29C43/32—Component parts, details or accessories; Auxiliary operations
- B29C43/58—Measuring, controlling or regulating
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B30—PRESSES
- B30B—PRESSES IN GENERAL
- B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
- B30B11/005—Control arrangements
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B30—PRESSES
- B30B—PRESSES IN GENERAL
- B30B15/00—Details of, or accessories for, presses; Auxiliary measures in connection with pressing
- B30B15/30—Feeding material to presses
- B30B15/302—Feeding material in particulate or plastic state to moulding presses
- B30B15/308—Feeding material in particulate or plastic state to moulding presses in a continuous manner, e.g. for roller presses, screw extrusion presses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C43/00—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
- B29C43/32—Component parts, details or accessories; Auxiliary operations
- B29C43/58—Measuring, controlling or regulating
- B29C2043/5833—Measuring, controlling or regulating movement of moulds or mould parts, e.g. opening or closing, actuating
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
- B29K2105/0005—Condition, form or state of moulded material or of the material to be shaped containing compounding ingredients
- B29K2105/0035—Medical or pharmaceutical agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
- B29K2105/25—Solid
- B29K2105/251—Particles, powder or granules
Definitions
- the present invention relates to a module for production of tablets, the module comprising : at least one inlet for an active pharmaceutical ingredient (API); at least one inlet for an excipient; at least one mixing unit; at least one analytical sensor; a tablet press; and at least one outlet for tablets. Furthermore, the invention relates to a method for continuous production of tablets.
- API active pharmaceutical ingredient
- PAT Process Analytical Technology
- the Agency considers PAT to be a system for designing, analysing, and controlling manufacturing through timely measurements (i.e., during processing) of critical quality and performance attributes of raw and in-process materials and processes, with the goal of ensuring final product quality.
- analytical in PAT is viewed broadly to include chemical, physical, microbiological, mathematical, and risk analysis conducted in an integrated manner.
- the goal of PAT is to enhance understanding and control the manufacturing process, which is consistent with our current drug quality system : quality cannot be tested into products; it should be built-in or should be by design.
- WO03/020499 does not take into account the interest in providing better process control as it is described in the PAT guidelines of the FDA.
- the process line includes a first mixing unit, a drying unit, a sizing unit and a second mixing unit.
- the output from the tabletting machine corresponds to the aggregated input of ingredients at the feed or inlet points, i.e. all of the material is fed to the tabletting machine in a continuous flow and at a constant rate. Due to a variety of factors, this is not feasible in practice. First, it is under any circumstances almost impossible to adjust the output from the mixing and drying units to provide a just-in-time supply of material to the tabletting machine. Second, the continuous production of tablets of a desired high level of quality requires careful monitoring, controlling and adjustment of process parameters in order to avoid a large rejection number from the tabletting machine. This may lead to accumulation of material along the process line awaiting adjustment of certain process parameters. In turn, this inevitably necessitates the use of intermediate buffer vessels in order to store material upstream of the tablet press.
- a module for production of tablets comprising : at least one inlet for an active pharmaceutical ingredient (API); at least one inlet for an excipient; at least one mixing unit; at least one analytical sensor; a tablet press; and at least one outlet for tablets; said module being characterized in that said inlets are in fluid communication with an inlet of the at least one mixing unit, an outlet of the at least one mixing unit is in fluid communication with an inlet of the tablet press, and an outlet of the tablet press is in fluid communication with the outlet for tablets; that the module is contained; and that said at least one analytical sensor is positioned to analyse the contents or properties upstream of the tablet press.
- API active pharmaceutical ingredient
- all units of the tabletting process may be contained, thus reducing the risk of operator exposure and facilitating operation of the tablet press, as all preparations of the material stream fed to the tablet press are carried out in a con- tained and controlled manner.
- the term "contained" within the context of the present application is defined by its level of containment according to suitable measurements, and is defined as at least dust-tight.
- a method for continuous production of tablets including the following steps: providing a contained module comprising at least two inlets, at least one mixing unit, at least one analytical sensor, a tablet press, and at least one outlet for tablets; feeding an active pharmaceutical ingredient (API) to one of said at least two inlets; feeding an excipient to the other of said at least two inlets; mixing the material stream comprising the API and the ex- cipient in said at least one mixing unit; measuring parameters of the contents of the material stream with said at least one analytical sensor upstream of the tablet press; controlling said two inlets and/or said mixing unit in response to the parameters measured; continuously supplying the tablet press with the material stream; controlling the speed of the tablet press in response to the parameters measured upstream of the tablet press, and discharging tablets at said at least one outlet.
- API active pharmaceutical ingredient
- the method according to the invention is fully continuous as every unit in the process line may be run without interruption and without the need for large buffer volumes along the line.
- This fully continuous feature is made possible by the arrangement of sensors upstream of the tablet press.
- This provides for a uniform quality of the material fed to the tablet press, as the monitoring, controlling and adjustment is carried out on the units located up- stream of the tablet press, the material fed to the tablet press thus being of a high, substantially constant quality.
- controlling the speed of the tablet press makes it possible to adjust the tablet press to the conditions upstream of the press.
- the improvement of the overall operational conditions aimed at have been attained, thus in turn improving the process efficiency as regards speed and quality, and eventually, the number of rejected tablets is brought down to a minimum
- Fig. 1 shows a schematic drawing of an embodiment of a contained module of the invention
- Fig. 2a shows a schematic drawing of another embodiment of a contained module of the invention with containers for API, excipient and product disconnected;
- Fig. 2b shows a schematic drawing corresponding to Fig. 2a of an embodiment of a contained module of the invention with containers for API, excipient and product connected;
- Fig. 3 shows a schematic drawing of a contained module according to a further embodiment of the invention.
- Fig. 4 shows a schematic overview of a process line for carrying out continuous production of tablets and corresponding in substance to the embodiment of the contained module of Fig. 3;
- Figs 5 to 7 show overviews corresponding to Fig. 4 of further embodiments.
- Fig. 8 shows a perspective view of an embodiment of the con- tained module according to the invention.
- Fig. 1 shows a schematic illustration of a module 1 according to the invention.
- the module 1 is a con- tained module, and the term "contained” is to be described in further detail below.
- streams of material flow of raw material, granulate, tablets etc.
- information flow from analytical sensors are indicated with punctuated lines with no indication of a direction of flow.
- the contained module 1 has two inlets in the form of a releasable inlet conduit 2 for an active pharmaceutical ingredients (API) and a releasable inlet conduit 3 for an excipient.
- API active pharmaceutical ingredients
- the releasable inlet conduits 2,3 are in fluid communication with an inlet of mixing unit 4.
- the term "mixing unit” should be understood in its broadest terms.
- the mixing unit refers to a unit operation generally capable of mixing two or more components into a desired form.
- a mixing unit may be capable of mixing two dry components, such as powders or granulates, into a mixture with a desired degree of homogeneity, such as substantially homogene- ous.
- the mixing unit may also be capable of modifying the physical form of dry components processed in the mixing unit, e.g. a feed stream of two or more powders may be converted to a granulate comprising the powder components.
- the mixing unit may be a granulator for making a granulate from dry powders, such as a dry granulator or roller compac- tor. Furthermore, the mixing unit may include such equipment as a dry blender, a continuous dry blender or the like.
- the module may also comprise a wet granulator as a mixing unit wherein the powders are granulated using a granulation liquid. It is preferred that the mixing unit is a granulator capable of producing a granulate from powders, such as fine powders.
- a drying unit may be provided, such as a fluid bed dryer.
- the material stream from mixing unit 4 may be analysed with an analytical sensor 51 before being conducted to an inlet of a tablet press 6.
- the tablet press 6 may be of any kind allowing suitable controlling of the settings of the press, such as speed, overfill height, feeder paddle speed, fill height, pre-compression force, pre-compression displacement, main compression force, and/or main compression displacement. Controlling the settings of the tablet press may involve controlling the compression profile, i.e. the height and width and/or the shape of the compression force-time curve per tablet, and/or the compression energy per tablet.
- One example of a method of controlling such a tablet press is disclosed in WO 2007/132281 (Courtoy).
- Tablets leaving tablet press 6 may be analysed using analytical sensor 52 before being conducted to an outlet, in the embodiment shown a releasable outlet port 7 for a tablet.
- rotary tablet presses as the above-mentioned are most advantageous, the use of other tablet making devices is conceivable as well.
- Such devices for producing tablets or tablet-like shapes may include a briquetting press, an extruder and a spheronizer, an extruder and a slicer or the like.
- the module of the invention comprises an "analytical sensor". Any analytical sensor appropriate for a given tabletting process may be employed.
- the analytical sensor may be adapted for optical analysis within the electromagnetic spectrum, and the analytical sensor may be capable of analysing parameters of tablets produced, such as weight, thickness and hardness, and/or chemical content, friability, disintegra- tion, dissolution etc.
- the module may also contain several sensors, which may be of the same or different types. The sensors are intended for analysing the contents or properties of the material stream upstream of the tablet press, i.e., the sensors should in principle be capable of analysing a number of parameters of the powder produced.
- An analytical sensor may be located at any stage in a process to be carried out in the module of the invention.
- an optical analytical sensor may analyse the API or an excipient entering the module via the respective inlet conduits, the material during mixing or granulation, material leaving a mixing unit, material entering the tablet press or tablets leaving the tablet press. Tablets leaving the tablet press may also be analysed for other parameter values, such as weight, thickness and hardness.
- An appropriate optical analytical sensor is described in the international application PCT/IB2008/051552, the contents of which are hereby incorporated by reference.
- a sensor for optical analysis may be contained in a "probe" further comprising other technical parts, such as a transmitting light guide, a receiving light guide, a measuring window, a deflecting mirror, and the probe may also comprise a calibrating element for calibrating the analytical sensor. Calibration may take the form of white balancing using an appropriate white standard calibration element, or the element may be a black standard calibration element or another type of calibration element as are well known within the art.
- the probe may further comprise a light source and a fibre-optic collector. Optical analysis may be performed in a reflective, transmissive or transflective mode.
- an electromagnetic system microwave or other EM spectral device
- the information from this sensor is used to control both the tablet press operation and the operation of the feed preparation systems which may include blending, dry granulation, fluid bed granulation, wet granulation, and/or particle formation by spray drying.
- the analytical sensor 52 downstream the tablet press 6 to analyze the contents or properties of the tablets ensures that any such features may be used in the production process.
- the module of Fig. 1 further has a control unit 8 capable of communicating with the analytical sensors 51,52 (as indicated with the punctuated lines). Control unit 8 may also communicate with the unit operations of the module 1 in order to send commands and thereby control the unit operations (lines of communication not shown).
- the module may furthermore comprise a "data processing unit".
- a computer or similar device which is capable of collecting signals from the analytical sensor(s) and converting them to data understandable to an operator.
- Data collected by the analytic sensor(s) may be presented to the operator in any appropriate way.
- the conversion of the data may involve simple statistical analysis, or the data may be analysed using "multivariate analysis", such as principal component analysis (PCA), principal component regression (PCR), partial least squares (PLS) or interval PLS (iPLS) modelling; multivariate statistical analysis is well- known within the field, and other techniques will be known to a person skilled in the art.
- PCA principal component analysis
- PCR principal component regression
- PLS partial least squares
- iPLS interval PLS
- the data is supplied to an external unit for processing.
- the control unit receives data or input from the data processing unit and/or, directly or indirectly, from the operator and send commands to the different unit operations contained in the module, e.g. to actuators controlling connection of API and excipient containers with the respective inlet conduits and the flow-rate of API and excipient to the mixing unit, to the mixing unit to control the processing rate in the mixing unit, to control the flow-rate of material applied to the tablet press, and the tablet compression speed (e.g. the turret speed of a rotary tablet press), and to actuators controlling connection of the product con- tainer with the outlet port.
- the control unit may for instance be adapted to control the compression profile, independently of the press speed. Alternatively, the control unit may be adapted to control the compression energy, independently of the press speed.
- the control unit may also control the analytical sensor(s) of the module, e.g. to control when and where an analysis is performed and the exact type of analysis to perform. It is conceivable to integrate the data processing unit and the control unit into one unit; such an integrated unit may invariably be referred to as a "control unit” so that unless otherwise indicated a control unit will also have the capabilities ascribed to the data processing unit above.
- control unit optical or electromagnetic methods are appropriate for analysis of solid, particulate materials. Such methods, based on for example photometric, spectropho- tometric or image analysis of powders, bulk materials, granules and the like, may be employed directly on materials, and appropriate analytical probes may be integrated in the manufacturing equipment.
- optical- or electromagnetic spectroscopic analytical methods comprise reflection/remission or transreflection (UV, VIS, NIR, IR), fluorescence or laser induced fluorescence (LIF), bio- or chemiluminescence or Raman spectroscopy.
- Optical analysis is also appropriate for liquid materials. Controlling the speed of the press could in principle mean varying the rotational speed of the turret of the tablet press; however, it is conceivable within the context of the present invention to include intermittent operation within the concept of "speed control".
- a cross- validation sampler may also be provided in the module.
- a cross- validation sampler may involve a complementary set of connections similar to those described above, so that a sample can be withdraw without dismantled the module or even interrupting the process performed in the module.
- the connection of the cross-validation sampler will be in communication with the material stream to be analysed for cross-validation; for example, via a tube or slide or the like allowing material to be withdrawn with the aid of gravity or by creating negative relative pressure in a tube.
- powders of an API and excipients are contained in the module, which are therefore segregated from the surrounding environment.
- the operator does not need to have any direct access to the individual unit operations during operation, which may be accesses via the respective releasable inlet conduits and outlet port.
- the fact that the module is contained likewise means that the module may be operated without need for further unit operations, and it may be viewed as a single integrated skid where excipients and API are loaded at a front end, i.e. the releasable inlet conduits, and it will then deliver tablets at the back end, i.e. the releasable outlet port.
- module should be interpreted as meaning either a single contained structure or a framework which enables the individual units of the framework to be assembled and tested prior to final installation. In this manner, delivery and final installation is made simpler and more cost-effective.
- the unit operations or components can be mounted in a skid-like frame structure. These unit operation frames are modular and can be connected to each other depending on the processing line layout. The frames can be moved from one processing room to another, or from one processing plant to another.
- the flexibility of the contained module allows that it is designed and constructed as a portable unit, which may easily be integrated with an existing process line in a phar- maceutical plant.
- the desired level of containment depends on, i.a., the toxicity of the API, and equipment should be chosen accordingly.
- containment levels approaching zero are conceivable, but may probably only be attained by such a radical approach as placing the entire tablet press into an isolator.
- handling such an isolated unit requires very large amounts of time for dismounting, cleaning and reassembly, which in turn leads to unacceptably long downtimes.
- a desired level of containment is chosen among such levels as contained or dust-tight (10-100 mcg/m 3 ), high contained (1-10 mcg/m 3 ) and total contained ( ⁇ 1 mcg/m 3 ), and suitable equipment is chosen in accordance with the desired containment levels.
- the term "contained" within the context of the present application is defined by its level of containment according to the SMEPAC test, or any corresponding, suitable measurement, and is thus defined as at least dust-tight according to the above- identified standard.
- releasable inlet conduits and product e.g. tablets
- releasable inlet conduits and product may be obtained from a releasable outlet port.
- releasable means that the respective inlet conduits and outlet port are generally closed, but may be opened to allow application of API and excipients to the module or remove tablets from the module, respectively.
- the releasable inlet conduits are designed so as to each comprise a conduit connection allowing the conduit connection to be connected to a complementary connection, so that when the connection of the inlet conduit is connected with the complementary connection, the releasable inlet conduit is "open".
- the complementary connection may be provided on a container for an API or an excipient; thereby the container for the API or the excipient may be connected with the respective inlet conduit via its connection and the complementary connection on the container. This will allow the API or excipient to be applied to the module, as appropriate, via the now open inlet conduit.
- the outlet port may also comprise a connection which may be connected via a complementary connection on a container for product exiting the module via the outlet port.
- a connection of an inlet conduit and its complementary connection on one container may be different from that of another inlet conduit and its respective complementary connection on another container, so that for example, a container for an API may only be connected to the inlet conduit for the API, and the ex- cipient container only to the inlet conduit for the excipient, and similarly the connection of the outlet port and its complementary connection on the product container may be different from those of either or both of the inlet conduits.
- the module should be allowed to be stripped down for cleaning in a contained manner, such that parts may be safely removed for washing and quickly replaced with clean components to allow the unit to resume production in the shortest practical time and without the delays and costs associated with traditional CIP.
- Figs 2a and 2b show an embodiment of the module, wherein the inlet conduits and the outlet port of the module 1 each comprise a connection 21,31,71 for connecting to a complementary connection 22,32,72 located on respective containers for API 91, excipient 92 and tablets 93.
- the releasable inlet conduit or outlet port connections are preferably in the form of so-called split valves having two mating valve members, such as split butterfly valves. This type of connection permits closing of the conduit or port passage and subsequently separation of the two valve parts, whereby each of the two mating valve members remains in its corresponding valve part closing the valve opening, practically without any leakage of the product to the surroundings.
- FIG. 2a schematically shows the containers 91,92,93 disconnected from the mod- ule 1
- Fig. 2b the containers 91,92,93 are shown as connected to the module 1 thus allowing access for the API and the excipient to the module 1 and allowing tablets to exit the module 1.
- Fig. 3 shows yet another embodiment of the module 1 of the invention.
- the module 1 is designed for two different excipients, so that an initial excipient may enter the module 1 from container 92a when the complementary connection 32a is mated with connection 31a.
- a further excipient such as a lubricant, e.g. magnesium stearate, may enter the module 1 from container 92b when the complementary connection 32b is mated with connection 31b.
- the further ex- cipient may be conducted, e.g. via hopper 20a, together with the material stream leaving an initial mixing unit 41, e.g. a granulate of API and initial excipient, to a further mixing unit 42.
- the material stream from mixing unit 42 may be analysed using analytical sensor 53 before enter- ing the tablet press 6.
- the module is not limited to any specific API, and API's may be in a dry, e.g. powdery or granular, form, or the API may be in a liquid form, such as a solution or an inherently liquid API.
- the module is not limited to a single API, and the module may comprise several inlet con- duits for different APIs with the intention to produce controlled release tablets capable of simultaneous or consecutive release of the different APIs.
- the excipient may be in the form of a powder or granules, in solution or liquid.
- excipients comprise anti-adherents, binders, coatings, disintegrants, fillers and diluents, flavours, colours, glidants, lubricants, preservatives, sorbents, and sweeteners; specific examples of the different types of excipient are well-known within the art.
- the module of the invention is not limited to a single inlet conduit for an API and a single inlet conduit for excipients. It is also con- ceivable that the module comprises an inlet conduit for an API and multiple inlet conduits for different excipients, as described in the embodiment of Fig. 3 and indicated in the overview of the process line of Fig. 4.
- the module may also comprise several inlet conduits for different APIs. Likewise, the module may comprise several mixing units located in the process line as needed.
- the module may comprise an inlet conduit for an API and an inlet conduit for a first excipient, such as a binder, a filler, a diluent, a flavour, a colour or the like, which inlet conduits are in fluid communication, e.g. via a hopper, with an inlet of a first mixing unit.
- This module may then comprise another inlet conduit for a second excipient, such as a lubricant, which inlet conduit for the second excipient is in fluid communication with an inlet of a second mixing unit.
- An outlet of the first mixing unit may also be in fluid communication with the inlet of the second mixing unit in order to obtain at an outlet of the second mixing unit a mixture of the material from the first mixing unit, i.e.
- the inlet of the second mixing unit may comprise a hopper or the like to receive the material stream from the first mixing unit and the second excipient from its inlet conduit.
- the material stream from an outlet of the second mixing unit may then be in fluid communication with an inlet of the tablet press to produce tablets from the mixture of the API and the first excipient with the second excipient.
- the tablet press is, via an outlet of the tablet press, in fluid communication with the outlet port for tablets.
- the module may comprise analytical sensors positioned to analyse material streams in the outlets of any of the mixing units, as well as analytical sensors positioned to analyse the tablets produced in the tablet press.
- the relative position in the process line of inlet conduits for API and/or excipient(s) and mixing units may thus depend on the function of a given excipient.
- introduction of a further excipient into the process line may taken into account the desired effect of the further excipient compared to the stage of API and initial excipients being processed in the module.
- an inlet conduit for a further excipient will introduce the excipient downstream of a mixing unit so that the ex- cipient may be mixed with the mixture, e.g.
- the same considerations apply when more than one API is introduced into the process line, e.g. when it is desired to produce a tablet containing more than one API, e.g. a controlled release tablet with simultaneous release of multiple APIs, or a controlled release tablet with consecutive release of different APIs, e.g. a multilayered tablet.
- the module may be established in a room in a building, or in a container designed for the purpose.
- the module has necessary connections such as e.g.
- the module may be contained by being in a confined space, but the concept of "containment” includes designing the individual parts of the process equipment to be “contained", all in all making up a "module” in the sense of containment.
- the module may also comprise other unit operations as necessary for a given tabletting process. For example, unit operations may be included to dry components introduced into the module, or feeders to move components from one unit operation to the next. Other relevant unit operations are mills, compactors, etc.
- the contained module may thus be seen as a single piece of equipment, allowing inlet of API's and excipients at one end, and outlet of tablets at the other.
- the single piece of equipment includes a physical confinement of the interfaces of the contained module.
- Such confinement may for instance be in the form of the above-mentioned designed valves, possibly supplemented with specially adapted tubing between the individual units of the module.
- the module 1 is designed for two different excipients, so that an initial excipient may enter the module 1 at the inlets to the module, together with the API, and is processed in the first mixing unit 41, which is in the form of a continuous dry blender (CDB).
- a further excipient such as a lubricant, e.g.
- magnesium stearate may enter the module 1 and is brought together with the material stream leaving the initial mixing unit 41 into a further mixing unit 42, which may also be in the form of a continuous dry blender.
- the material stream may be analysed in any suitable manner and at any suitable positions as described in the above before entering the tablet press 6.
- the material stream of the process line overview of Fig. 5 is directed via a roller compactor 43 com- pacting the material before it enters the further mixing unit 42.
- the mixing unit comprises a twin screw blender 44 (TSB) as indicated in Fig. 6, to which the material stream of API and ex- cipients entering the module through the inlets is conducted.
- TSG twin screw granulator 45
- the material stream is guided to segmented dryer 5 and further to a mill 46.
- the further excipient such as a lubricant, e.g. magnesium stearate, enters the module at this point and is brought together with the existing material stream, this mixture being blended in a small batch blender 47 before being fed to the tablet press 6.
- the material streams of API and excipients are brought together in the initial mixing unit 41, in the form of continuous dry blender, and then brought to the twin screw granulator 45 (thus not via the twin screw blender 44), and further through the dryer 5, mill 46, small batch blender 47 and then to tablet press 6.
- continuous is meant that the process running in the module is under conditions approaching or at a steady-state meaning that the application rates of API and excipients (as expressed in mass units) are approximately identical to the production rate of tablets (likewise expressed in mass units).
- the application and production rates do not, however, need to be the same throughout for a given process and may be adjusted as desired.
- a container for an API or an excipient When a container for an API or an excipient is empty, it may be disconnected from its respective releasable inlet and be replaced with a full container without need for interrupting the process.
- a product container is full it may also be replaced with an empty container without need for interrupting the process, the re- leasable inlet conduits and the releasable outlet port thus allowing that the module is operated on a continuous basis.
- the speed of tablet press is controlled in accordance with the upstream unit operations. This means that the raw material entering into the module via the API and excipients inlets is processed in the mixing unit or units, compacted, dried etc. at any suitable rate. In the upstream process, analysis, control and adjustment is carried out to bring the powder flow within any set standard for the finished tablets.
- the entire module and process line may be run with a minimum of aggregated material awaiting further processing, i.e. with a minimum of buffer volume.
- the disadvantages connected with large buffer volume and consequent back-mixing are reduced or even eliminated.
- Minimizing the buffer volume and back-mixing enables product traceability throughout the line, for instance by time stamping, enabling further to join and correlate tablet data with data of the powder that is used to make that particular tablet or subset of tablets. Correlation of tablet data with the correct powder data enables better process understanding
- control unit may contain a pre-programmed sequence of events, or the control unit may be operated manually by an operator to control the individual process steps, or a combination of manual and pre-programmed operation. It is preferred however, that the control unit is programmed to employ data from the data processing unit to control the process parame- ters in a "feed-back" type operation or in a "feed -forward" type operation.
- a parameter may be analysed by an analytical sensor downstream or upstream of a certain processing step so that the data processing unit may send a signal to the unit operation of the step upstream or downstream of the analysis point in order to adjust the processing step based on the data from the sensor.
- the control of the module according to the invention by the method disclosed entails using the information derived from the mathematical model. This includes predicting for instance dissolution, and then continuously or "quasi" continuously provide feedback to the steps in the process including granulation and drying and tabletting.
- the information from the tablet press is used for instance for weight control variation to feed back and adjust the properties of the granulation process.
- the information from the tablet press such as e.g.
- the ejection force may be used to control the addition and blending of the lubricant.
- the information derived from the granulation and drying steps may be used to adjust the settings of the tablet press, e.g. feeder settings and compression profile.
- the compression roller compensation system may be used to enable the compression profile to be controlled independent of the speed of the tab- let press.
- a continuous process according to the invention may run for extended periods of time, e.g. 60 hours or more.
- the control unit may therefore also comprise a timing device, and a module with an analytical sensor may have an appropriately programmed control unit for carrying out so-called auto-analysis according to predetermined schedule.
- the control unit may then employ data from the analytical sensor(s) to maintain desired conditions by implementing adjustments to the process steps or maintaining process parameters unadjusted as appropriate.
- the control unit may also record an analysis history of the process as well as a history of any adjustments made in the process.
- an initial mixing unit 41 is shown, being in fluid communication with inlets for API and excipients, for instance in the form of a powder hopper.
- the contained module 1 furthermore comprises a feeding device, such as a twin screw feeder.
- the mixing unit may be of the type ConsigmaTM (Collette), which is a continuous high shear granulation and drying system designed for plug flow, i.e. operating on a first-in first-out principle, thus avoiding the above-mentioned undesirable back mixing.
- the contained module 1 includes a segmented fluid bed dryer 5.
- the mixing unit 41 may as shown be installed on a post hoist to allow for easy manual powder loading and then hoisted above dryer, for a direct vertical, gravita- tional feed into the dryer.
- the ConsigmaTM (or other mixing unit) can be placed below, to be fed with bigger powder IBCs and a pneumatic wet conveying into the dryer 5.
- Reference numeral 46 indicates a mill, provided with an evaluation unit (not shown) and may also be provided with a small batch blender (not shown), to add magnesium stearate or other lubricant, or other further excipients.
- the contained module 1 includes a tablet press 6.
- the shown arrangement of the contained module is a horizontal, single floor set-up including pneumatic conveying between the individual units. Alternatively one could use a vertical set-up, with gravitational transport rather than pneumatic.
- the invention should not be regarded as being limited to the embodiments shown and described in the above. Several modifications and combinations are conceivable within the scope of the appended claims.
Abstract
Description
Claims
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09786382.3A EP2427166B1 (en) | 2009-05-07 | 2009-05-07 | Tablet production module and method for continuous production of tablets |
US13/319,023 US9713575B2 (en) | 2009-05-07 | 2009-05-07 | Tablet production module and method for continuous production of tablets |
BRPI0925048A BRPI0925048B8 (en) | 2009-05-07 | 2009-05-07 | module for tablet production and method for continuous tablet production |
PCT/IB2009/051885 WO2010128359A1 (en) | 2009-05-07 | 2009-05-07 | Tablet production module and method for continuous production of tablets |
JP2012509101A JP2012525895A (en) | 2009-05-07 | 2009-05-07 | Tablet manufacturing module and tablet continuous manufacturing method |
ES09786382.3T ES2441446T3 (en) | 2009-05-07 | 2009-05-07 | Pill production module and method for continuous pill production |
PT97863823T PT2427166E (en) | 2009-05-07 | 2009-05-07 | Tablet production module and method for continuous production of tablets |
DK09786382.3T DK2427166T3 (en) | 2009-05-07 | 2009-05-07 | Tablet Preparation Module and Method for Continuous Tablet Preparation |
CN2009801590959A CN102438578A (en) | 2009-05-07 | 2009-05-07 | Tablet production module and method for continuous production of tablets |
HRP20131155AT HRP20131155T1 (en) | 2009-05-07 | 2013-12-03 | Tablet production module and method for continuous production of tablets |
US15/204,222 US10016340B2 (en) | 2009-05-07 | 2016-07-07 | Tablet production module and method for continuous production of tablets |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2009/051885 WO2010128359A1 (en) | 2009-05-07 | 2009-05-07 | Tablet production module and method for continuous production of tablets |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/319,023 A-371-Of-International US9713575B2 (en) | 2009-05-07 | 2009-05-07 | Tablet production module and method for continuous production of tablets |
US15/204,222 Division US10016340B2 (en) | 2009-05-07 | 2016-07-07 | Tablet production module and method for continuous production of tablets |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010128359A1 true WO2010128359A1 (en) | 2010-11-11 |
Family
ID=41479620
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2009/051885 WO2010128359A1 (en) | 2009-05-07 | 2009-05-07 | Tablet production module and method for continuous production of tablets |
Country Status (10)
Country | Link |
---|---|
US (2) | US9713575B2 (en) |
EP (1) | EP2427166B1 (en) |
JP (1) | JP2012525895A (en) |
CN (1) | CN102438578A (en) |
BR (1) | BRPI0925048B8 (en) |
DK (1) | DK2427166T3 (en) |
ES (1) | ES2441446T3 (en) |
HR (1) | HRP20131155T1 (en) |
PT (1) | PT2427166E (en) |
WO (1) | WO2010128359A1 (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013182869A1 (en) | 2012-06-04 | 2013-12-12 | Gea Process Engineering Nv | Feeder unit, a feeder module comprising a plurality of feeder units, and method for discharging a constant mass flow of one or more powders into a receiving container |
WO2013182870A1 (en) | 2012-06-04 | 2013-12-12 | Gea Process Engineering Nv | Feeder module and method for providing a mixture of one or more powders to a receiving container |
WO2014207510A1 (en) | 2013-06-27 | 2014-12-31 | Gea Process Engineering Nv | Method for continuous production of tablets, tabletting system for carrying out the method, and use of the tabletting system for the production of tablets of at least two ingredients containing particles with a significant difference in particle size |
EP3117894A1 (en) * | 2015-06-15 | 2017-01-18 | Kikusui Seisakusho Ltd. | Powdery material mixing and feeding device and compression molding machine including the same |
EP3225388A1 (en) * | 2016-03-29 | 2017-10-04 | Kikusui Seisakusho Ltd. | Powdery material mixing degree measurement device, powdery material mixing and feeding system, and compression molding machine including the same |
EP3238929A1 (en) | 2016-03-29 | 2017-11-01 | Kikusui Seisakusho Ltd. | Molded product production system |
US9840499B2 (en) | 2007-12-07 | 2017-12-12 | Vertex Pharmaceuticals Incorporated | Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid |
RU2644723C2 (en) * | 2012-01-25 | 2018-02-13 | Вертекс Фармасьютикалз Инкорпорейтед | Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzonic acid |
US10076513B2 (en) | 2010-04-07 | 2018-09-18 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof |
US10231932B2 (en) | 2013-11-12 | 2019-03-19 | Vertex Pharmaceuticals Incorporated | Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases |
US10260807B2 (en) | 2013-07-05 | 2019-04-16 | Freund Corporation | Drying device and continuous granule production system |
US10302602B2 (en) | 2014-11-18 | 2019-05-28 | Vertex Pharmaceuticals Incorporated | Process of conducting high throughput testing high performance liquid chromatography |
US10626111B2 (en) | 2004-01-30 | 2020-04-21 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
EP3165355B1 (en) | 2015-09-30 | 2021-07-14 | Fette Compacting GmbH | Method for operating a rotary tablet press and rotary tablet press |
US11931462B2 (en) | 2020-06-16 | 2024-03-19 | Fette Compacting Gmbh | Method for product tracking in an installation |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8969386B2 (en) | 2007-05-09 | 2015-03-03 | Vertex Pharmaceuticals Incorporated | Modulators of CFTR |
CA2707494C (en) | 2007-12-07 | 2018-04-24 | Vertex Pharmaceuticals Incorporated | Processes for producing cycloalkylcarboxamido-pyridine benzoic acids |
NZ602030A (en) | 2008-02-28 | 2014-02-28 | Vertex Pharma | Heteroaryl derivatives as cftr modulators |
JP6787881B2 (en) | 2014-08-15 | 2020-11-18 | マサチューセッツ インスティテュート オブ テクノロジー | Systems and methods for synthesizing chemical products containing active pharmaceutical ingredients |
US10689873B2 (en) | 2016-03-10 | 2020-06-23 | Lonza Ltd | Customizable facility |
CA3017165A1 (en) | 2016-03-10 | 2017-09-14 | Lonza Ltd | Customizable facility |
JP6681756B2 (en) * | 2016-03-16 | 2020-04-15 | 株式会社菊水製作所 | Control device for rotary powder compression molding machine |
JP6681764B2 (en) * | 2016-03-29 | 2020-04-15 | 株式会社菊水製作所 | Molded product manufacturing system |
US11185839B2 (en) | 2016-05-02 | 2021-11-30 | Massachusetts Institute Of Technology | Reconfigurable multi-step chemical synthesis system and related components and methods |
JP6792001B2 (en) * | 2016-07-01 | 2020-11-25 | メディシナル バイオコンバージェンス リサーチ センター | Composition for diagnosing thyroid cyst cancer using aminoacyl-tRNA synthetase-related protein expression level and diagnostic marker detection method |
JP7116975B2 (en) * | 2016-08-31 | 2022-08-12 | フロイント産業株式会社 | Deviation processing device and deviation processing method |
DE102016218135A1 (en) | 2016-09-21 | 2018-03-22 | Robert Bosch Gmbh | Production module for the production of solid dosage forms |
EP3335868B1 (en) * | 2016-12-12 | 2021-06-09 | Kikusui Seisakusho Ltd. | Controller and control method for rotary compression molding machine |
AU2018221725B2 (en) | 2017-02-17 | 2024-02-01 | Massachusetts Institute Of Technology | Systems and methods for the fabrication of tablets, including pharmaceutical tablets |
EP3450126A1 (en) | 2017-09-01 | 2019-03-06 | Hexion Research Belgium SA | Multi-component mixing and metering equipment with online stoichiometry control |
CN111278404B (en) * | 2017-09-21 | 2023-05-09 | 豪夫迈·罗氏有限公司 | Pharmaceutical facility and method for manufacturing pharmaceutical product |
JP7224612B2 (en) * | 2017-10-06 | 2023-02-20 | 株式会社菊水製作所 | Molded product handling system |
CN109902892A (en) * | 2017-12-08 | 2019-06-18 | 中国石油化工股份有限公司 | Security work responsibility system optimization method based on process label |
EP3757566A4 (en) * | 2018-02-22 | 2021-09-08 | Mitsubishi Chemical Engineering Corporation | Continuous manufacturing system and method |
JP2019154862A (en) * | 2018-03-14 | 2019-09-19 | 清水建設株式会社 | Continuous type drug preparation apparatus and continuous type drug preparation method |
JP2018183817A (en) * | 2018-06-20 | 2018-11-22 | ヘーエーアー プロセス エンジニアリング ナームロゼ フェンノートシャップ | Method for continuous production of tablets, tableting system for carrying out the method, and use of the tableting system for the production of tablets of at least two ingredients containing particles with a significant difference in particle size |
GB2578272B (en) * | 2018-07-10 | 2023-03-29 | Innopharma Res Limited | Apparatus and method for the production of solid dosage forms |
PT3833964T (en) * | 2018-08-07 | 2023-08-17 | Norton Waterford Ltd | Application of raman spectroscopy for the manufacture of inhalation powders |
CN113873903A (en) * | 2019-01-07 | 2021-12-31 | 弗里茨·施密特 | Method for qualitatively and/or quantitatively detecting substance contained in cannabis plant and kit used therein |
JP7300708B2 (en) * | 2019-04-01 | 2023-06-30 | 株式会社菊水製作所 | Processing system using powder and its control method |
EP3756640A1 (en) | 2019-06-26 | 2020-12-30 | Fette Compacting GmbH | System and method for continuous production of solid dosage forms |
DE102019218379A1 (en) * | 2019-11-27 | 2021-05-27 | Glatt Ingenieurtechnik Gesellschaft mit beschränkter Haftung | Modular system and process for the production of bulk pharmaceutical form |
EP4005764A1 (en) * | 2020-11-26 | 2022-06-01 | Fette Compacting GmbH | Feeding and blending system for a system for continuous processing of powder products |
EP4005663A1 (en) | 2020-11-26 | 2022-06-01 | Fette Compacting GmbH | Powder blender for a system for continuous processing of powder products |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0275834A1 (en) * | 1986-12-29 | 1988-07-27 | Warner-Lambert Company | Continuous process for producing a comestible tablet |
WO2003020499A1 (en) * | 2001-09-05 | 2003-03-13 | Courtoy Nv | A rotary tablet press and a method of cleaning such a press |
WO2003070149A1 (en) * | 2002-02-22 | 2003-08-28 | Tecnea Engineering S.R.L. | Process for the preparation of compositions and apparatus embodying the process |
WO2008056021A2 (en) * | 2006-11-10 | 2008-05-15 | Atacama Labs Oy | Granules, tablets and granulation |
WO2008104923A2 (en) * | 2007-02-27 | 2008-09-04 | Collette Nv | Continuous granulating and drying apparatus including measurement units and method of continuous granulation and drying |
WO2009134848A1 (en) * | 2008-04-30 | 2009-11-05 | Novartis Ag | Continuous process for making pharmaceutical compositions |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61133131A (en) | 1984-11-29 | 1986-06-20 | Kyowa Hakko Kogyo Co Ltd | Compression molding machine provided with device for feeding fixed amount of particulate matter and mixing |
DK196786A (en) | 1986-04-29 | 1987-10-30 | Ebbe Busch Larsen | PROCEDURE AND MEASURES FOR MANAGING A FEED MIXTURE PLANT |
GB9004781D0 (en) | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
JPH0434445A (en) | 1990-05-30 | 1992-02-05 | Ricoh Co Ltd | Electrophotographic device |
JPH066148B2 (en) * | 1991-01-16 | 1994-01-26 | 株式会社菊水製作所 | Method and device for checking tablets under reduced pressure in a rotary powder molding machine |
DE4315680C2 (en) | 1993-05-05 | 1996-02-29 | Korsch Maschfab | Regulation of tablet parameters during production on rotary presses |
DE4342962C1 (en) | 1993-12-16 | 1995-02-02 | Buck Chem Tech Werke | Device for coupling containers |
US5504332A (en) | 1994-08-26 | 1996-04-02 | Merck & Co., Inc. | Method and system for determining the homogeneity of tablets |
DE9416619U1 (en) | 1994-10-15 | 1995-01-12 | Bohle L B Pharmatech Gmbh | Device for deburring and dusting tablets |
US5760399A (en) | 1995-10-02 | 1998-06-02 | Foss Nirsystems, Inc. | Measurement of transmission spectra of pharmaceutical tablets |
CZ154398A3 (en) | 1995-11-23 | 1998-08-12 | Janssen Pharmaceutica N.V. | Solid mixtures of cyclodextrins prepared by melt extrusion |
JPH09271996A (en) * | 1996-04-05 | 1997-10-21 | Sankyo Co Ltd | Device for automatically forming tablet |
DE19721467A1 (en) | 1997-05-22 | 1998-11-26 | Basf Ag | Process for the preparation of small-scale preparations of biologically active substances |
JPH11276553A (en) | 1998-03-26 | 1999-10-12 | Jgc Corp | Method and device for manufacturing solid preparation |
JP4817573B2 (en) | 1999-10-13 | 2011-11-16 | 協和発酵バイオ株式会社 | Compression molded product and method for producing the same |
CN100342846C (en) | 1999-10-13 | 2007-10-17 | 协和发酵工业株式会社 | Compression molded product and production method therefor |
US20010034848A1 (en) | 2000-02-15 | 2001-10-25 | Gail Langley | Key card for personal home page access |
EP1157736A1 (en) | 2000-05-20 | 2001-11-28 | Glatt Maschinen- und Apparatebau AG | Device and process for the quasi-continuous treatment of granular material |
US6499984B1 (en) | 2000-05-22 | 2002-12-31 | Warner-Lambert Company | Continuous production of pharmaceutical granulation |
ITRN20000051A1 (en) | 2000-12-22 | 2002-06-22 | Ascor Chimici Srl | METHOD AND EQUIPMENT TO FORM COMPOSITE SPHERES CONTAINING ACTIVE INGREDIENTS OF THE PHARMACEUTICAL TYPE AND / OR FOOD OR COSMETIC SUPPLEMENTS |
ITBO20010082A1 (en) | 2001-02-15 | 2002-08-16 | Ima Spa | COMPRESSING MACHINE FOR THE PRODUCTION OF TABLETS |
CA2451135C (en) | 2001-06-20 | 2012-10-09 | Takeda Chemical Industries, Ltd. | Method of manufacturing tablet |
JP2003267480A (en) | 2002-03-14 | 2003-09-25 | Niigata Eng Co Ltd | Powdery particle feeding unit and powdery particle feeding method |
WO2003087740A1 (en) | 2002-04-04 | 2003-10-23 | Euro-Celtique, S.A. | Method and apparatus for determining the homogeneity of a granulation during tableting |
DE10218220C1 (en) * | 2002-04-18 | 2003-06-26 | Korsch Ag | Production of tablets involves carrying out servicing, maintenance and cleaning operations externally in sealed operating state of tablet press in inner chamber of press |
US7930053B2 (en) | 2003-12-23 | 2011-04-19 | Beacons Pharmaceuticals Pte Ltd | Virtual platform to facilitate automated production |
DE102004008321B3 (en) | 2004-02-20 | 2005-11-17 | Fette Gmbh | Method and device for quality control in the manufacture of tablets |
EP1600761B1 (en) | 2004-05-27 | 2007-07-11 | Uhlmann VisioTec GmbH | Tabletting press with integrated NIR measurement device |
JP2008513205A (en) | 2004-09-21 | 2008-05-01 | グラクソ グループ リミテッド | Mixing system and method |
DE102005061787A1 (en) | 2005-12-23 | 2007-06-28 | Fette Gmbh | Device for generating a negative pressure in the sealed space of a tablet press and / or an insulator |
DE102006002359B4 (en) | 2006-01-18 | 2009-01-02 | Fette Gmbh | Apparatus and method for monitoring the production of tablets in a rotary press |
DE102006017196B4 (en) | 2006-04-12 | 2008-09-11 | Fette Gmbh | Method of controlling the amount of active ingredient of tablets during production in a rotary tablet press |
AU2007248613A1 (en) | 2006-05-04 | 2007-11-15 | Novartis Ag | Heated roller compaction process for making pharmaceutical compositions |
US7771632B2 (en) | 2006-05-15 | 2010-08-10 | American Leistritz Extruder Corp. | Continuous melt spheronization apparatus and process for the production of pharmaceutical pellets |
JP5140071B2 (en) | 2006-05-15 | 2013-02-06 | クールトイ・ナムローゼ・フェンノートシャップ | Method for controlling tablet molding machine and tablet molding machine |
WO2008071181A2 (en) | 2006-12-15 | 2008-06-19 | Gea Pharma Systems Ag | Coupling closure, and docking device comprising two of said coupling closures |
JP2008183168A (en) * | 2007-01-30 | 2008-08-14 | Ebara Corp | Tablet manufacturing system |
KR100955669B1 (en) | 2007-08-13 | 2010-05-06 | 한올바이오파마주식회사 | Combination preparation comprising inhibitor of ?????? reductase and aspirin and method for manufacturing the same |
WO2009130539A1 (en) | 2008-04-23 | 2009-10-29 | Gea Process Engineering (Nps) Ltd. | Apparatus for analysing solid, particulate material and method of analysing using the apparatus |
US20100221374A1 (en) * | 2009-02-16 | 2010-09-02 | Le Floc H Jean Y | Modular tablet press and coater |
-
2009
- 2009-05-07 DK DK09786382.3T patent/DK2427166T3/en active
- 2009-05-07 PT PT97863823T patent/PT2427166E/en unknown
- 2009-05-07 JP JP2012509101A patent/JP2012525895A/en active Pending
- 2009-05-07 WO PCT/IB2009/051885 patent/WO2010128359A1/en active Application Filing
- 2009-05-07 EP EP09786382.3A patent/EP2427166B1/en not_active Revoked
- 2009-05-07 BR BRPI0925048A patent/BRPI0925048B8/en not_active IP Right Cessation
- 2009-05-07 CN CN2009801590959A patent/CN102438578A/en active Pending
- 2009-05-07 ES ES09786382.3T patent/ES2441446T3/en active Active
- 2009-05-07 US US13/319,023 patent/US9713575B2/en active Active
-
2013
- 2013-12-03 HR HRP20131155AT patent/HRP20131155T1/en unknown
-
2016
- 2016-07-07 US US15/204,222 patent/US10016340B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0275834A1 (en) * | 1986-12-29 | 1988-07-27 | Warner-Lambert Company | Continuous process for producing a comestible tablet |
WO2003020499A1 (en) * | 2001-09-05 | 2003-03-13 | Courtoy Nv | A rotary tablet press and a method of cleaning such a press |
WO2003070149A1 (en) * | 2002-02-22 | 2003-08-28 | Tecnea Engineering S.R.L. | Process for the preparation of compositions and apparatus embodying the process |
WO2008056021A2 (en) * | 2006-11-10 | 2008-05-15 | Atacama Labs Oy | Granules, tablets and granulation |
WO2008104923A2 (en) * | 2007-02-27 | 2008-09-04 | Collette Nv | Continuous granulating and drying apparatus including measurement units and method of continuous granulation and drying |
WO2009134848A1 (en) * | 2008-04-30 | 2009-11-05 | Novartis Ag | Continuous process for making pharmaceutical compositions |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10626111B2 (en) | 2004-01-30 | 2020-04-21 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
US11084804B2 (en) | 2005-11-08 | 2021-08-10 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
US9840499B2 (en) | 2007-12-07 | 2017-12-12 | Vertex Pharmaceuticals Incorporated | Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid |
US10597384B2 (en) | 2007-12-07 | 2020-03-24 | Vertex Pharmaceuticals Incorporated | Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid |
US10076513B2 (en) | 2010-04-07 | 2018-09-18 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof |
US11052075B2 (en) | 2010-04-07 | 2021-07-06 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof |
RU2644723C2 (en) * | 2012-01-25 | 2018-02-13 | Вертекс Фармасьютикалз Инкорпорейтед | Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzonic acid |
WO2013182869A1 (en) | 2012-06-04 | 2013-12-12 | Gea Process Engineering Nv | Feeder unit, a feeder module comprising a plurality of feeder units, and method for discharging a constant mass flow of one or more powders into a receiving container |
US11479374B2 (en) | 2012-06-04 | 2022-10-25 | Gea Procss Engineering Nv | Feeder unit, feeder module comprising feeder units, and method for discharging a constant mass flow of one or more powders into a receiving container |
EP3489636A1 (en) | 2012-06-04 | 2019-05-29 | GEA Process Engineering nv | Feeder unit, a feeder module comprising a plurality of feeder units, and method for discharging a constant mass flow of one or more powders into a receiving container |
US10501213B2 (en) | 2012-06-04 | 2019-12-10 | Gea Process Engineering Nv | Feeder unit, feeder module comprising feeder units, and method for discharging a constant mass flow of one or more powders into a receiving container |
WO2013182870A1 (en) | 2012-06-04 | 2013-12-12 | Gea Process Engineering Nv | Feeder module and method for providing a mixture of one or more powders to a receiving container |
US9713910B2 (en) | 2013-06-27 | 2017-07-25 | Gea Process Engineering Nv | Tabletting system |
WO2014207510A1 (en) | 2013-06-27 | 2014-12-31 | Gea Process Engineering Nv | Method for continuous production of tablets, tabletting system for carrying out the method, and use of the tabletting system for the production of tablets of at least two ingredients containing particles with a significant difference in particle size |
US10260807B2 (en) | 2013-07-05 | 2019-04-16 | Freund Corporation | Drying device and continuous granule production system |
US10231932B2 (en) | 2013-11-12 | 2019-03-19 | Vertex Pharmaceuticals Incorporated | Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases |
US10302602B2 (en) | 2014-11-18 | 2019-05-28 | Vertex Pharmaceuticals Incorporated | Process of conducting high throughput testing high performance liquid chromatography |
US10632703B2 (en) | 2015-06-15 | 2020-04-28 | Kikusui Seisakusho Ltd. | Powdery material mixing and feeding device and compression-molding machine including the same |
EP3117894A1 (en) * | 2015-06-15 | 2017-01-18 | Kikusui Seisakusho Ltd. | Powdery material mixing and feeding device and compression molding machine including the same |
EP3165355B1 (en) | 2015-09-30 | 2021-07-14 | Fette Compacting GmbH | Method for operating a rotary tablet press and rotary tablet press |
EP3238929A1 (en) | 2016-03-29 | 2017-11-01 | Kikusui Seisakusho Ltd. | Molded product production system |
EP3225388A1 (en) * | 2016-03-29 | 2017-10-04 | Kikusui Seisakusho Ltd. | Powdery material mixing degree measurement device, powdery material mixing and feeding system, and compression molding machine including the same |
US11173638B2 (en) | 2016-03-29 | 2021-11-16 | Kikusui Seisakusho Ltd. | Molded product production system |
US11931462B2 (en) | 2020-06-16 | 2024-03-19 | Fette Compacting Gmbh | Method for product tracking in an installation |
Also Published As
Publication number | Publication date |
---|---|
CN102438578A (en) | 2012-05-02 |
BRPI0925048A2 (en) | 2015-08-04 |
ES2441446T3 (en) | 2014-02-04 |
DK2427166T3 (en) | 2014-01-27 |
BRPI0925048B8 (en) | 2021-06-22 |
US20160310365A1 (en) | 2016-10-27 |
EP2427166B1 (en) | 2013-10-16 |
HRP20131155T1 (en) | 2014-02-28 |
US10016340B2 (en) | 2018-07-10 |
JP2012525895A (en) | 2012-10-25 |
EP2427166A1 (en) | 2012-03-14 |
BRPI0925048B1 (en) | 2019-07-09 |
US9713575B2 (en) | 2017-07-25 |
PT2427166E (en) | 2014-01-20 |
US20120061869A1 (en) | 2012-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10016340B2 (en) | Tablet production module and method for continuous production of tablets | |
JP5918808B2 (en) | Tablet manufacturing module and tablet continuous manufacturing method | |
Vanhoorne et al. | Recent progress in continuous manufacturing of oral solid dosage forms | |
Simonaho et al. | Continuous manufacturing of tablets with PROMIS-line—Introduction and case studies from continuous feeding, blending and tableting | |
EP3013571B1 (en) | Method for continuous production of tablets, tabletting system for carrying out the method, and use of the tabletting system for the production of tablets of at least two ingredients containing particles with a significant difference in particle size | |
JP6775311B2 (en) | Molded product manufacturing system | |
JP6681764B2 (en) | Molded product manufacturing system | |
RU2522127C2 (en) | Bulk products measuring device (versions), method and use of bulk material measuring device | |
JP6752034B2 (en) | Powder mixing measuring device, powder mixing supply system, method for manufacturing compression molded products | |
US20220258114A1 (en) | System and method for continuous processing of powder products | |
EP2508252A1 (en) | Coating apparatus | |
EP3515581B1 (en) | Production module and method for producing solid medicaments | |
WO2020130088A1 (en) | Continuous production system and continuous production method | |
Manley et al. | Characterizing drug product continuous manufacturing residence time distributions of major/minor excipient step changes using near infrared spectroscopy and process parameters | |
WO2019163059A1 (en) | Continuous manufacturing system and method | |
CN106109251A (en) | Tablet produces module and for the method producing tablet continuously | |
CN113165755A (en) | Continuous production of filled capsules and method therefor | |
Van Snick | Experimental and model-based analysis of a continuous direct compression platform for oral solid dosage manufacturing | |
WO2009130539A1 (en) | Apparatus for analysing solid, particulate material and method of analysing using the apparatus | |
Warman et al. | Leveraging a Mini-Batchwise Continuous Direct Compression (CDC) Approach to Optimize Efficiency in Process Development, On-Demand Manufacturing, and Continuous Process Verification (CPV) | |
Verstraeten | Model-based process analytical technology in continuous manufacturing | |
JP2018183817A (en) | Method for continuous production of tablets, tableting system for carrying out the method, and use of the tableting system for the production of tablets of at least two ingredients containing particles with a significant difference in particle size | |
EP3515583B1 (en) | Fluidised bed system | |
Pauli | Development and Implementation of a Redundant Process Control Strategy in Pharmaceutical Continuous Manufacturing | |
CN216458631U (en) | Traditional chinese medicine granule serialization production facility and traditional chinese medicine granule production system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980159095.9 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09786382 Country of ref document: EP Kind code of ref document: A1 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2009786382 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012509101 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 8843/DELNP/2011 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13319023 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: PI0925048 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: PI0925048 Country of ref document: BR Kind code of ref document: A2 Effective date: 20111104 |